Journal of Clinical and Experimental Ophthalmology
Open Access

Abstract

Intravitreal Vascular Endothelium Growth Factor Inhibitors for Retinal Macroaneurysms

Carlos Menezes and Carla Teixeira

Last year our group published the case of a foveal longstanding retinal macroaneurysm successfully treated with intravitreal ranibizumab. A few previous and subsequent studies also reported the safety and effectiveness of intravitreal vascular endothelium growth factor inhibitors (anti-VEGF) in other more common cases of retinal macroaneurysms. In this commentary we proposed to make a brief review of this entity, particularly of its complications and its management with emphasis on anti-VEGF therapy